Response: Sensitization initiated

Por Azab, Abdel Kareem, Ghobrial, Irene M.
Publicado em 2009

Biological Insights into Myeloma and Other B Cell Malignancies

Por Fulciniti, Mariateresa, Amodio, Nicola, Cea, Michele, Maiso, Patricia, Azab, Abdel Kareem
Publicado no Biomed Res Int (2016)

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy

Por Muz, Barbara, de la Puente, Pilar, Azab, Feda, Azab, Abdel Kareem
Publicado no Hypoxia (Auckl) (2015)

Molecularly Targeted Therapies in Multiple Myeloma

Por de la Puente, Pilar, Muz, Barbara, Azab, Feda, Luderer, Micah, Azab, Abdel Kareem
Publicado em 2014

Spotlight on ixazomib: potential in the treatment of multiple myeloma

Por Muz, Barbara, Ghazarian, Rachel Nicole, Ou, Monica, Luderer, Micah John, Kusdono, Hubert Daniel, Azab, Abdel Kareem
Publicado no Drug Des Devel Ther (2016)

Direct measurement of hypoxia in a xenograft multiple myeloma model by optical-resolution photoacoustic microscopy

Por Imai, Toru, Muz, Barbara, Yeh, Cheng-Hung, Yao, Junjie, Zhang, Ruiying, Azab, Abdel Kareem, Wang, Lihong
Publicado no Cancer Biol Ther (2017)

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib

Por Muz, Barbara, Azab, Feda, de la Puente, Pilar, Rollins, Scott, Alvarez, Richard, Kawar, Ziad, Azab, Abdel Kareem
Publicado no Biomed Res Int (2015)

A CD138-Independent Strategy to Detect Minimal Residual Disease and Circulating Tumour Cells in Multiple Myeloma

Por Muz, Barbara, de la Puente, Pilar, Azab, Feda, Luderer, Micah, King, Justin, Vij, Ravi, Azab, Abdel Kareem
Publicado no Br J Haematol (2016)

Drug Delivery Approaches for the Treatment of Cervical Cancer

Por Ordikhani, Farideh, Erdem Arslan, Mustafa, Marcelo, Raymundo, Sahin, Ilyas, Grigsby, Perry, Schwarz, Julie K., Azab, Abdel Kareem
Publicado no Pharmaceutics (2016)

Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib: Potentiation of nilotinib by CXCR4 antagonist

Por Weisberg, Ellen, Azab, Abdel Kareem, Manley, Paul W., Kung, Andrew L., Christie, Amanda L., Bronson, Rod, Ghobrial, Irene M., Griffin, James D.
Publicado em 2011

3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma

Por de la Puente, Pilar, Muz, Barbara, Gilson, Rebecca C, Azab, Feda, Luderer, Micah, King, Justin, Achilefu, Samuel, Vij, Ravi, Azab, Abdel Kareem
Publicado no Biomaterials (2015)

microRNA-dependent modulation of histone acetylation in Waldenström macroglobulinemia

Por Roccaro, Aldo M., Sacco, Antonio, Jia, Xiaoying, Azab, Abdel Kareem, Maiso, Patricia, Ngo, Hai T., Azab, Feda, Runnels, Judith, Quang, Phong, Ghobrial, Irene M.
Publicado em 2010

The myeloid binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting

Por Lu, Zhi Hong, Kaliberov, Sergey, Zhang, Jingzhu, Muz, Barbara, Azab, Abdel Kareem, Sohn, Rebecca E., Kaliberova, Lyudmila, Du, Yingqiu, Curiel, David T., Arbeit, Jeffrey M.
Publicado em 2014

A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma

Por Luderer, Micah John, Muz, Barbara, de la Puente, Pilar, Chavalmane, Sanmathi, Kapoor, Vaishali, Marcelo, Raymundo, Biswas, Pratim, Thotala, Dinesh, Rogers, Buck, Azab, Abdel Kareem
Publicado no Pharm Res (2016)

Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia

Por de la Puente, Pilar, Weisberg, Ellen, Muz, Barbara, Nonami, Atsushi, Luderer, Micah, Stone, Richard M., Melo, Junia V., Griffin, James D., Azab, Abdel Kareem
Publicado no Leuk Res (2015)

CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma

Por Azab, Abdel Kareem, Sahin, Ilyas, Azab, Feda, Moschetta, Michele, Mishima, Yuji, Burwick, Nicholas, Zimmermann, Johann, Romagnoli, Barbara, Patel, Kalpana, Chevalier, Eric, Roccaro, Aldo M., Ghobrial, Irene M.
Publicado em 2014

Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenström macroglobulinemia

Por Roccaro, Aldo M., Sacco, Antonio, Aujay, Monette, Ngo, Hai T., Azab, Abdel Kareem, Azab, Feda, Quang, Phong, Maiso, Patricia, Runnels, Judith, Anderson, Kenneth C., Demo, Susan, Ghobrial, Irene M.
Publicado em 2010

Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stro...

Por de la Puente, Pilar, Quan, Nancy, Hoo, Ryan Soo, Muz, Barbara, Gilson, Rebecca C., Luderer, Micah, King, Justin, Achilefu, Samuel, Salama, Noha Nabil, Vij, Ravi, Azab, Abdel Kareem
Publicado no Haematologica (2016)

Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom Macroglobulinemia

Por Ngo, Hai T., Azab, Abdel Kareem, Farag, Mena, Jia, Xiaoying, Melhem, Molly M., Runnels, Judith, Roccaro, Aldo M., Azab, Feda, Sacco, Antonio, Leleu, Xavier, Anderson, Kenneth C., Ghobrial, Irene M.
Publicado em 2009

The eIF2-alpha kinase HRI is a novel therapeutic target in multiple myeloma

Por Burwick, Nicholas, Zhang, Michael Y, de la Puente, Pilar, Azab, Abdel Kareem, Hyun, Teresa S, Ruiz-Gutierrez, Melisa, Sanchez-Bonilla, Marilyn, Nakamura, Tomoka, Delrow, Jeffrey J, MacKay, Vivian L, Shimamura, Akiko
Publicado no Leuk Res (2017)